Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

Article  PubMed  Google Scholar 

Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol [Internet]. 2017;41:3–14. https://doi.org/10.1016/j.bpobgyn.2016.08.006.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Chang LC, Huang CF, Lai MS, Shen LJ, Wu FLL, Cheng WF. Prognostic factors in epithelial ovarian cancer: a population-based study. PLoS One. 2018;13(3):1–11.

Article  Google Scholar 

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96.

Article  PubMed  PubMed Central  Google Scholar 

Pignata S, Cecere SC, Du Bois A, Harter P, Heitz F. Treatment of recurrent ovarian cancer. Ann Oncol [Internet]. 2017;28(Supplement 8):viii51-6. https://doi.org/10.1093/annonc/mdx441.

Article  CAS  PubMed  Google Scholar 

Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis revisited, revised, and expanded. Am J Pathol [Internet]. 2016;186(4):733–47. https://doi.org/10.1016/j.ajpath.2015.11.011.

Article  PubMed  Google Scholar 

Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31–46.

Article  CAS  PubMed  Google Scholar 

Fister S, Günthert AR, Emons G, Gründker C. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo. Cancer Res. 2007;67(4):1750–6.

Article  CAS  PubMed  Google Scholar 

Çiftci HB. Structures, functions and expressions of GnRH and GnRH receptor in peripheral reproductive organs and their regulation by estradiol-17β. Iran J Appl Anim Sci [Internet]. 2015;5(4):775–86.

Google Scholar 

Terada KY, Ahn HJ, Kessel B. Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial. J Gynecol Oncol. 2016;27(3):1–8.

Article  Google Scholar 

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, et al. Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC). J Ovarian Res [Internet]. 2017;10(1):1–8. https://doi.org/10.1186/s13048-016-0300-5.

Article  CAS  Google Scholar 

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, et al. A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression. Sci Rep [Internet]. 2016;6(April):1–9. https://doi.org/10.1038/srep25408.

Article  CAS  Google Scholar 

Gründker C, Günthert AR, Millar RP, Emons G. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab. 2002;87(3):1427–30.

Article  PubMed  Google Scholar 

Huang H, Li YJ, Lan CY, Huang QD, Feng YL, Huang YW, et al. Clinical significance of ascites in epithelial ovarian cancer. Neoplasma. 2013;60(5):546–52.

Article  CAS  PubMed  Google Scholar 

Eicke N, Günthert AR, Emons G, Gründker C. GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells. Int J Oncol. 2006;29(5):1223–9.

CAS  PubMed  Google Scholar 

Gründker, Emons G. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer. 2021

Gründker C, Völker P, Schulz KD, Emons G. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist Cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers. Gynecol Oncol. 2000;78(2):194–202.

Article  PubMed  Google Scholar 

Gründker C, Völker P, Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein αI-mediated activation of phosphotyrosine phosphatase. Endocrinology. 2001;142(6):2369–80.

Article  PubMed  Google Scholar 

Fister S, Günthert AR, Aicher B, Paulini KW, Emons G, Gründker C. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein bax. Cancer Res. 2009;69(16):6473–81.

Article  CAS  PubMed  Google Scholar 

Darby S, Stockley J, Khan MM, Robson CN, Leung HY, Gnanapragasam VJ. Expression of GnRH type II is regulated by the androgen receptor in prostate cancer. Endocrine-Related Cancer Endocr Relat Cancer [Internet]. 2007;14(3):613–24.

Article  CAS  PubMed  Google Scholar 

Park S, Han JM, Cheon J, Hwang JI, Seong JY. Apoptotic death of prostate cancer cells by a gonadotropin-releasing hormone-II antagonist. PLoS One. 2014;9(6):e99723.

Article  PubMed  PubMed Central  Google Scholar 

Gründker C, Emons G. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer. 2003;7:1–7.

Limonta P, Moretti RM, Marelli MM, Motta M. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol [Internet]. 2003;24(4):279–95.

Article  CAS  PubMed  Google Scholar 

Dong-Ki K, Ji SY, Kaushik M, Jong-Ik H, Kyungjin K, Dongseung S, et al. A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells. Cancer Res. 2009;69(3):923–31.

Article  Google Scholar 

Varghese F, Bukhari AB, Malhotra R, De A. IHC profiler: An open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9(5):e96801.

Article  PubMed  PubMed Central  Google Scholar 

Zucha M, Silawani S, Dewanto A, Widad S, Taufiqurrachman I, Kusumanto A, et al. Expression of GnRH receptor type-II correlates with proliferation activity in endometriosis. Int J Infertil Fetal Med. 2022;13(2):37–41.

Google Scholar 

Elgamal A, Amin L. Evaluation of topical application of platelets rich plasma and hyaluronic acid on the healing of experimentally induced tongue ulcer. Egypt Dent J. 2022;68(1):355–69.

Article  Google Scholar 

Menon SS, Guruvayoorappan C, Sakthivel KM, Rasmi RR. Ki-67 protein as a tumour proliferation marker. Clin Chim Acta [Internet]. 2019;491(November 2018):39–45. https://doi.org/10.1016/j.cca.2019.01.011.

Article  CAS  PubMed  Google Scholar 

Sobecki M, Mrouj K, Colinge J, Gerbe F, Jay P, Krasinska L, et al. Cell-cycle regulation accounts for variability in Ki-67 expression levels. Cancer Res. 2017;77(10):2722–34.

Article  CAS  PubMed  Google Scholar 

Soliman NA, Yussif SM. Ki-67 as a prognostic marker according to breast cancer molecular subtype. Cancer Biol Med. 2016;13(4):496–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rödel F, Zhou S, Győrffy B, Raab M, Sanhaji M, Mandal R, et al. The prognostic relevance of the proliferation markers Ki-67 and Plk1 in early-stage ovarian cancer patients with serous, low-grade carcinoma based on mrna and protein expression. Front Oncol. 2020;10(October):1–10.

Google Scholar 

Safitri WR. Analisis Korelasi Pearson Dalam Menentukan Hubungan Antara Kejadian Demam Berdarah Dengue Dengan Kepadatan Penduduk Di Kota Surabaya Pada Tahun 2012–2014. J Ilm Keperawatan (Scientific J Nursing). 2016;2(2):21–9.

Google Scholar 

Liu Q, Zhou X, Feng W, Pu T, Li X, Li F, et al. Gonadotropin-releasing hormone receptor-targeted near-infrared fluorescence probe for specific recognition and localization of peritoneal metastases of ovarian cancer. Front Oncol. 2020;10(February):1–13.

Google Scholar 

Kheiri SA, Kunna A, Babiker AY, Alsuhaibani SA, Ahmed RY, Alsammani MA. Histopathological pattern and age distribution, of malignant ovarian tumor among sudanese ladies. Open Access Maced J Med Sci. 2018;6(2):237–41.

Article  PubMed  PubMed Central  Google Scholar 

Sindiani A, Obeidat B, Hamadeh L, Alghazo S, Al-Mohtaseb A, Alshdaifat E. A descriptive study of the clinico-pathological and surgical characteristics of patients with primary epithelial ovarian cancer. A cross sectional study. Ann Med Surg [Internet]. 2020;59:254–7.

Article  Google Scholar 

Singla A. Epidemiology and risk factors for ovarian cancer. In: Preventive oncology for the gyne. Singapore: Springer Singapore; 2019. p. 223–31.